Wright Bonilla Quoted on Isolation/Purification Distinction

05 August 2011 FDA Week News

Foley Partner Jacqueline Wright Bonilla was quoted in an article that appeared in FDA Week on August 5, 2011 titled "Gene Patent Ruling’s Isolation v. Purification Distinction Could Impact Biotech." Wright Bonilla discusses a federal court ruling on DNA patent eligibility that distinguishes between the terms isolation and purification. She states that the distinction is not clearly defined with regards to non-nucleic acid biologics and pharma molecules, adding that this distinction might be determined on a product-by-product basis and influence how attorneys draft their patent claims.

Insights

Act Now: Employer Obligations Under New York HERO Act
02 August 2021
Labor & Employment Law Perspectives
$15 Minimum Wage for Federal Government Contractors Starting in January 2022
02 August 2021
Labor & Employment Law Perspectives
Supreme Court Limits Patent Assignor Estoppel
02 August 2021
PharmaPatents
Review of Recent Whistleblower Developments
30 July 2021
Legal News: Whistleblower Developments
30th Annual Law of Product Distribution & Franchise Seminar
29 September | 7 & 20 October 2021
Milwaukee | Chicago | Dallas
7th National Telehealth Summit
4-5 October 2021
Miami Beach, FL
AHLA Fraud & Compliance Forum
21-22 September 2021
Baltimore, MD
2nd Clinical Trial Agreements Forum
16-17 September 2021
Online Livestream